These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 38791315

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of Ox-LDL and LOX-1 in Atherogenesis.
    Kattoor AJ, Kanuri SH, Mehta JL.
    Curr Med Chem; 2019; 26(9):1693-1700. PubMed ID: 29737246
    [Abstract] [Full Text] [Related]

  • 4. LOX-1 and obesity.
    Yan M, Mehta JL, Hu C.
    Cardiovasc Drugs Ther; 2011 Oct; 25(5):469-76. PubMed ID: 21881850
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    Mehta JL.
    Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
    Reiss AB, Anwar K, Wirkowski P.
    Curr Med Chem; 2009 Aug; 16(21):2641-52. PubMed ID: 19601801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
    Yao Y, Wang Y, Zhang Y, Liu C.
    Lipids Health Dis; 2017 Apr 13; 16(1):77. PubMed ID: 28407763
    [Abstract] [Full Text] [Related]

  • 12. Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression.
    Wang Z, Guo X, Zhang Q, Du G, Zeng Z, Zheng C, Wei Y.
    Int J Med Sci; 2021 Apr 13; 18(16):3652-3664. PubMed ID: 34790037
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K.
    J Neurosurg; 2014 Sep 13; 121(3):621-30. PubMed ID: 24949677
    [Abstract] [Full Text] [Related]

  • 16. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.
    Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL.
    Am J Med Sci; 2011 Aug 13; 342(2):135-42. PubMed ID: 21747278
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1.
    Jiang J, Yan M, Mehta JL, Hu C.
    Cardiovasc Drugs Ther; 2011 Oct 13; 25(5):461-8. PubMed ID: 21968594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor.
    El-Hajjar L, Hindieh J, Andraos R, El-Sabban M, Daher J.
    Int J Mol Sci; 2022 Mar 04; 23(5):. PubMed ID: 35269979
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.